サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1683666

体外診断の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測

Global In Vitro Diagnostics Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 252 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
体外診断の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 252 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

体外診断の世界市場規模は、2024年の896億4,000万米ドルから2033年には1,261億6,000万米ドルに成長し、2026～2033年の予測期間中に3.87％の堅調な年間平均成長率（CAGR）を示すと予測されます。

体外診断（IVD）市場は、慢性疾患の蔓延と早期かつ正確な診断ソリューションに対する需要の高まりにより、大幅な成長を遂げようとしています。血液、尿、組織などのサンプルを用いて実施される体外診断（IVD）検査は、疾病の発見、モニタリング、管理において重要な役割を果たしています。医療プロバイダーが個別化医療と予防医療をますます優先するようになるにつれ、先進的体外診断技術に対する需要が高まると予想されます。分子診断、ポイントオブケア検査、自動化における技術革新は、診断プロセスの精度と効率を高め、市場の成長をさらに後押ししています。

体外診断の技術的進歩もこの市場の将来を形成しています。迅速検査法の開発とデータ分析における人工知能と機械学習の統合は、診断の実施方法に革命をもたらしています。これらの技術革新により、医療専門家はタイムリーな結果を得ることができ、迅速な意思決定と患者の転帰の改善が促進されます。さらに、患者が便利で利用しやすい診断ソリューションを求めていることから、在宅検査や遠隔医療への動向の高まりが体外診断市場にプラスの影響を与えそうです。

さらに、新興国における医療インフラの拡大は、体外診断市場にプラスの影響を与えると予想されます。アジア太平洋やラテンアメリカなどの地域で医療へのアクセスが改善し、質の高い診断サービスへの需要が高まるにつれ、体外診断の消費は増加します。特定地域のニーズに合わせた革新的でコスト効率の高い診断ソリューションの開発に注力する企業は、市場シェアを獲得する上で有利な立場にあると考えられます。体外診断市場が発展するにつれて、技術の進歩、規制の変更、消費者の嗜好の変化などが相互に影響し合い、成長と革新の機会に満ちたダイナミックな環境が形成されると考えられます。

当社のレポートは、様々な産業や市場に関する包括的かつ実用的な洞察を顧客に提供するために、綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます。

市場概要：市場概要：定義、分類、産業の現状など、市場に関する詳細なイントロダクション。

市場促進要因：市場成長に影響を与える主要促進要因・抑制要因・市場促進要因・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場参入企業の包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を記載しています。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域による市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネス機会を理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象セグメントを特定します。将来の市場開拓と成長展望に関する洞察を記載しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 体外診断産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 産業動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原料分析
    • 原料リスト
    • 原料メーカー一覧
    • 主要原料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 体外診断の世界市場分析：製品タイプ別

  • 製品タイプ別概要
  • 製品タイプ別過去・予測データ分析
  • 検査機器
  • 試薬
  • ソフトウェア
  • サービス

第6章 体外診断の世界市場分析：技術別

  • 技術別概要
  • 技術別過去・予測データ分析
  • 免疫測定
  • 臨床化学
  • 分子診断学
  • 血液学
  • 微生物学
  • 凝固
  • その他

第7章 体外診断の世界市場分析：用途別

  • 用途別概要
  • 用途別過去・予測データ分析
  • 感染症
  • 腫瘍学
  • 循環器
  • 腎臓内科
  • 自己免疫疾患
  • その他

第8章 体外診断の世界市場分析：エンドユーザー別

  • エンドユーザー別概要
  • エンドユーザー別過去・予測データ分析
  • 病院
  • 診断ラボ
  • 学術研究機関
  • その他

第9章 体外診断の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第10章 体外診断企業の競合情勢

  • 体外診断市場の競合
  • 提携・協力・協定
  • 合併・買収
  • 新製品の上市
  • その他の開発

第11章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Roche Diagnostics
  • Abbott Laboratories
  • Siemens Healthineers
  • Danaher Corporation
  • Thermo Fisher Scientific
  • Becton
  • Dickinson And Company（BD）
  • Bio-Rad Laboratories
  • BioMAfA（C）Rieux
  • Qiagen
  • Hologic
  • Sysmex Corporation
  • Ortho Clinical Diagnostics
  • Agilent Technologies
  • Illumina"
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product Type ( and USD MN)
  • Instruments Market Sales By Geography ( and USD MN)
  • Reagents Market Sales By Geography ( and USD MN)
  • Software Market Sales By Geography ( and USD MN)
  • Services Market Sales By Geography ( and USD MN)
  • Analysis By Technology ( and USD MN)
  • Immunoassay Market Sales By Geography ( and USD MN)
  • Clinical Chemistry Market Sales By Geography ( and USD MN)
  • Molecular Diagnostics Market Sales By Geography ( and USD MN)
  • Hematology Market Sales By Geography ( and USD MN)
  • Microbiology Market Sales By Geography ( and USD MN)
  • Coagulation Market Sales By Geography ( and USD MN)
  • Others Market Sales By Geography ( and USD MN)
  • Analysis By Application ( and USD MN)
  • Infectious Diseases Market Sales By Geography ( and USD MN)
  • Oncology Market Sales By Geography ( and USD MN)
  • Cardiology Market Sales By Geography ( and USD MN)
  • Nephrology Market Sales By Geography ( and USD MN)
  • Autoimmune Diseases Market Sales By Geography ( and USD MN)
  • Others Market Sales By Geography ( and USD MN)
  • Analysis By End-User ( and USD MN)
  • Hospitals Market Sales By Geography ( and USD MN)
  • Diagnostic Laboratories Market Sales By Geography ( and USD MN)
  • Academic and Research Institutes Market Sales By Geography ( and USD MN)
  • Others Market Sales By Geography ( and USD MN)
  • Global In Vitro Diagnostics Market Sales By Geography ( and USD MN)
  • North America Market Analysis ( and USD MN)
  • United States Market Analysis ( and USD MN)
  • Canada Market Analysis ( and USD MN)
  • Mexico Market Analysis ( and USD MN)
  • Europe Market Analysis ( and USD MN)
  • Europe Market Estimate By Country ( and USD MN)
  • United Kingdom Market Analysis ( and USD MN)
  • France Market Analysis ( and USD MN)
  • Germany Market Analysis ( and USD MN)
  • Italy Market Analysis ( and USD MN)
  • Russia Market Analysis ( and USD MN)
  • Spain Market Analysis ( and USD MN)
  • Rest of Europe Market Analysis ( and USD MN)
  • Asia Pacific Market Analysis ( and USD MN)
  • China Market Analysis ( and USD MN)
  • Japan Market Analysis ( and USD MN)
  • India Market Analysis ( and USD MN)
  • South Korea Market Analysis ( and USD MN)
  • Australia Market Analysis ( and USD MN)
  • South East Asia Market Analysis ( and USD MN)
  • Rest of Asia Pacific Market Analysis ( and USD MN)
  • Latin America Market Analysis ( and USD MN)
  • Brazil Market Analysis ( and USD MN)
  • Argentina Market Analysis ( and USD MN)
  • Peru Market Analysis ( and USD MN)
  • Chile Market Analysis ( and USD MN)
  • Rest of Latin America Market Analysis ( and USD MN)
  • Middle East & Africa Market Analysis ( and USD MN)
  • Saudi Arabia Market Analysis ( and USD MN)
  • UAE Market Analysis ( and USD MN)
  • Israel Market Analysis ( and USD MN)
  • South Africa Market Analysis ( and USD MN)
  • Rest of Middle East and Africa Market Analysis ( and USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of In Vitro Diagnostics Report
  • Market Research Process
  • Market Research Methodology
  • Global In Vitro Diagnostics Market Size, By Region ( and USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product Type
  • Market Attractiveness Analysis By Technology
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product Type ( and USD MN)
  • Instruments Market Sales By Geography ( and USD MN)
  • Reagents Market Sales By Geography ( and USD MN)
  • Software Market Sales By Geography ( and USD MN)
  • Services Market Sales By Geography ( and USD MN)
  • Global Market Analysis By Technology ( and USD MN)
  • Immunoassay Market Sales By Geography ( and USD MN)
  • Clinical Chemistry Market Sales By Geography ( and USD MN)
  • Molecular Diagnostics Market Sales By Geography ( and USD MN)
  • Hematology Market Sales By Geography ( and USD MN)
  • Microbiology Market Sales By Geography ( and USD MN)
  • Coagulation Market Sales By Geography ( and USD MN)
  • Others Market Sales By Geography ( and USD MN)
  • Global Market Analysis By Application ( and USD MN)
  • Infectious Diseases Market Sales By Geography ( and USD MN)
  • Oncology Market Sales By Geography ( and USD MN)
  • Cardiology Market Sales By Geography ( and USD MN)
  • Nephrology Market Sales By Geography ( and USD MN)
  • Autoimmune Diseases Market Sales By Geography ( and USD MN)
  • Others Market Sales By Geography ( and USD MN)
  • Global Market Analysis By End-User ( and USD MN)
  • Hospitals Market Sales By Geography ( and USD MN)
  • Diagnostic Laboratories Market Sales By Geography ( and USD MN)
  • Academic and Research Institutes Market Sales By Geography ( and USD MN)
  • Others Market Sales By Geography ( and USD MN)
  • Global Market Sales ( and USD MN)
  • North America Market Sales ( and USD MN)
  • Europe Market Sales ( and USD MN)
  • Asia Pacific Market Sales ( and USD MN)
  • Latin America Market Sales ( and USD MN)
  • Middle East & Africa Market Sales ( and USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11218520

Global In Vitro Diagnostics Market size is anticipated to grow from USD 89.64 Billion in 2024 to USD 126.16 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 3.87% during the forecast period of 2026 to 2033.

The in vitro diagnostics (IVD) market is poised for substantial growth, driven by the increasing prevalence of chronic diseases and the rising demand for early and accurate diagnostic solutions. IVD tests, which are performed on samples such as blood, urine, and tissue, play a critical role in disease detection, monitoring, and management. As healthcare providers increasingly prioritize personalized medicine and preventive care, the demand for advanced IVD technologies is expected to rise. Innovations in molecular diagnostics, point-of-care testing, and automation are enhancing the accuracy and efficiency of diagnostic processes, further propelling market growth.

Technological advancements in IVD are also shaping the future of this market. The development of rapid testing methods and the integration of artificial intelligence and machine learning in data analysis are revolutionizing the way diagnostics are performed. These innovations enable healthcare professionals to obtain timely results, facilitating quicker decision-making and improved patient outcomes. Additionally, the growing trend towards home-based testing and telemedicine is likely to influence the IVD market positively, as patients seek convenient and accessible diagnostic solutions.

Moreover, the expansion of healthcare infrastructure in emerging economies is expected to positively impact the in vitro diagnostics market. As access to healthcare improves and the demand for quality diagnostic services increases in regions such as Asia-Pacific and Latin America, the consumption of IVD products will rise. Companies that focus on developing innovative and cost-effective diagnostic solutions tailored to specific regional needs will be well-positioned to capture market share. As the IVD market evolves, the interplay of technological advancements, regulatory changes, and shifting consumer preferences will create a dynamic environment ripe with opportunities for growth and innovation.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product Type

  • Instruments
  • Reagents
  • Software
  • Services

By Technology

  • Immunoassay
  • Clinical Chemistry
  • Molecular Diagnostics
  • Hematology
  • Microbiology
  • Coagulation
  • Others

By Application

  • Infectious Diseases
  • Oncology
  • Cardiology
  • Nephrology
  • Autoimmune Diseases
  • Others

By End-User

  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Institutes
  • Others
  • COMPANIES PROFILED
  • Roche Diagnostics
  • Abbott Laboratories
  • Siemens Healthineers
  • Danaher Corporation
  • Thermo Fisher Scientific
  • Becton
  • Dickinson and Company (BD)
  • Bio-Rad Laboratories
  • bioMA(C)rieux
  • Qiagen
  • Hologic
  • Sysmex Corporation
  • Ortho Clinical Diagnostics
  • Agilent Technologies
  • Illumina"
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. IN VITRO DIAGNOSTICS INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Technology
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End-User
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL IN VITRO DIAGNOSTICS MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1. Overview By Product Type
  • 5.2. Historical and Forecast Data Analysis By Product Type
  • 5.3. Instruments Historic and Forecast Sales By Regions
  • 5.4. Reagents Historic and Forecast Sales By Regions
  • 5.5. Software Historic and Forecast Sales By Regions
  • 5.6. Services Historic and Forecast Sales By Regions

6. GLOBAL IN VITRO DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY

  • 6.1. Overview By Technology
  • 6.2. Historical and Forecast Data Analysis By Technology
  • 6.3. Immunoassay Historic and Forecast Sales By Regions
  • 6.4. Clinical Chemistry Historic and Forecast Sales By Regions
  • 6.5. Molecular Diagnostics Historic and Forecast Sales By Regions
  • 6.6. Hematology Historic and Forecast Sales By Regions
  • 6.7. Microbiology Historic and Forecast Sales By Regions
  • 6.8. Coagulation Historic and Forecast Sales By Regions
  • 6.9. Others Historic and Forecast Sales By Regions

7. GLOBAL IN VITRO DIAGNOSTICS MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. Infectious Diseases Historic and Forecast Sales By Regions
  • 7.4. Oncology Historic and Forecast Sales By Regions
  • 7.5. Cardiology Historic and Forecast Sales By Regions
  • 7.6. Nephrology Historic and Forecast Sales By Regions
  • 7.7. Autoimmune Diseases Historic and Forecast Sales By Regions
  • 7.8. Others Historic and Forecast Sales By Regions

8. GLOBAL IN VITRO DIAGNOSTICS MARKET ANALYSIS BY END-USER

  • 8.1. Overview By End-User
  • 8.2. Historical and Forecast Data Analysis By End-User
  • 8.3. Hospitals Historic and Forecast Sales By Regions
  • 8.4. Diagnostic Laboratories Historic and Forecast Sales By Regions
  • 8.5. Academic and Research Institutes Historic and Forecast Sales By Regions
  • 8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL IN VITRO DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE IN VITRO DIAGNOSTICS COMPANIES

  • 10.1. In Vitro Diagnostics Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF IN VITRO DIAGNOSTICS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Roche Diagnostics
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Abbott Laboratories
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Siemens Healthineers
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Danaher Corporation
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Thermo Fisher Scientific
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Becton
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Dickinson And Company (BD)
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Bio-Rad Laboratories
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. BioMAfA(C)Rieux
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Qiagen
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Hologic
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Sysmex Corporation
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments
  • 11.15. Ortho Clinical Diagnostics
    • 11.15.1 Company Overview
    • 11.15.2 Company Revenue
    • 11.15.3 Products
    • 11.15.4 Recent Developments
  • 11.16. Agilent Technologies
    • 11.16.1 Company Overview
    • 11.16.2 Company Revenue
    • 11.16.3 Products
    • 11.16.4 Recent Developments
  • 11.17. Illumina"
    • 11.17.1 Company Overview
    • 11.17.2 Company Revenue
    • 11.17.3 Products
    • 11.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies